About Chrisofix®
Discover the people and technology behind Chrisofix®. Explore how our orthoses work, find product-specific information and contact us for support or partnership enquiries.
About us
To enhance patient well-being by providing innovative, high-quality orthoses and medical devices that alleviate limb pain, accelerate recovery, and improve overall quality of life. Leveraging 25 years of expertise and continuous patient feedback, we design, develop, and manufacture our products in state-of-the-art R&D facilities in Switzerland and Hungary.
CHRISOFIX®® holds several industry-trendsetter patents internationally, and further patents are under registration.
CHRISOFIX® AG and CHRISOFIX® HUNGARY Ltd. (previously ORKRISZ Ltd) are privately owned companies. They are responsible for designing, developing, manufacturing, and sale a world-wide patented product range of orthopedic splints/orthoses. The two legally independent companies represent two closely related independent parts: central services (Chrisofix® AG, Switzerland) and the production plant (Chrisofix® Hungary Ltd, Hungary).
The first patent on CHRISOFIX®® technology was filed by Dr. Kálmán Bolla, the founder of CHRISOFIX® Ltd. (Schaffhausen, Switzerland) at the end of 1995. The manufacturing of the CHRISOFIX®® products was started in 1997 by Orkrisz Ltd. (Budapest). Since then, CHRISOFIX® Ltd. has been continuously extending its product range by developing new, patent-protected splinting technologies and products.
The CHRISOFIX®® technology is the newest fixation method characterized by combining the advantages of circular (e.g. plaster of Paris, thermoplastic materials) and segmental fixations (splints and orthoses). The use of CHRISOFIX®® products makes the splinting quicker and more economical than the earlier developed limb fixation methods At the end of 2020 the Chrisofix® group was sold to professional private investors, and with a new management and ambitious business strategy the company is being prepared for improve the relationship with its existing partners, and for further scale-up and to conquer new markets, worldwide.
The new management is determined to keep the core values of CHRISOFIX®® set by the founders, and to build long-lasting partnerships with all existing and future partners.
Chrisofix®® AG Switzerland Board
Andras S. Czeller
Vice Chairman of the board
Andras is a serial entepreneur with proven track record in the fields of energy industry, international trading, business – and software development.
Stefan Juhasz
Chairman of the board
Stefan has been in the financial industry since 1998. He is founder and co-owner of an independent asset management company headquartered in Zurich, Switzerland.
Dr. Margit Kása
Advisor to the board
As an advisor to the board of Chrisofix® AG, Dr. Margit Kása, drawing on decades of medical experience, directly supports the work of the Board and the Chrisofix® team, and indirectly contributes to the healing of thousands of patients who use our products worldwide.
Dr. Judit Hetthéssy PhD
Advisor to the board
Judit graduated from Semmelweis University in 2005 and holds specialist qualifications in orthopedics, traumatology, and hand surgery, as well as the European Board of Hand Surgery Diploma. She worked as a hand surgeon at Semmelweis University from 2014 to 2021, becoming lead hand surgeon in 2018. She currently advises the Chrisofix® board and is a member of its professional team.
Chrisofix®® Management
Laszlo Budai
CEO
Laszlo has 10+ years of management experience in the online and energetic sectors (Google, Schibsted Media/Adevinta, E.On), spent 3 years as the GM of the successful ALAP Labs Incubator Inc. and managed several successful startup companies from start to validation and market entry.
Ildiko Nagy
COO
Ildikó boasts over two decades of experience in the medical device manufacturing and sales industry. Her work is consistently marked by a solution-focused mindset.
Zsolt Gyongyosi
CFO
Judit Roza
Project Manager
Monika Jady
Office Manager, Switzerland
Monika worked in the education sector and in the media. She has been writing articles for diverse magazines since 2003. She has started to work at Chrisofix® AG in July 2021.
Norbert Mocsar
Project Manager, MDR, ISO and registrations
Norbert is an expert in MDR, FDA and other regulatory systems and product registration processes. He has an eye for detail and plays a key role in ensuring that Chrisofix® can smoothly distribute its products in 30+ countries in compliance with local regulations.
Why Chrisofix®?
Swiss development in immobilisation for more than 30 years
The first patent application for Chrisofix® technology was filed in 1995; manufacturing began in Hungary in 1997. The Swiss and Hungarian companies together provide the development and manufacturing expertise.
The corrugated aluminium core allows the shape to be adjusted. The appropriate shell and fastening together serve the intended purpose of each product.
Millions of products have helped patients on their recovery journey worldwide.